Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Bassi

Showing results (261-270 of 422) with videos related to

Pageof 43
Sort By:
Journal of Gastrointestinal Oncology|April 2, 2016
Variation of tumoral marker after radiofrequency ablation of pancreatic adenocarcinomaMirko D'Onofrio, Emilio Barbi, Roberto Girelli, et al.
Frontiers in Nutrition|June 29, 2023
Independent effect of fat-to-muscle mass ratio at bioimpedance analysis on long-term survival in patients receiving surgery for pancreatic cancerMarta Sandini, Salvatore Paiella, Marco Cereda, et al.
Annals of Surgery|October 9, 2019
Perioperative Interstitial Fluid Expansion Predicts Major Morbidity Following Pancreatic Surgery: Appraisal by Bioimpedance Vector AnalysisMarta Sandini, Salvatore Paiella, Marco Cereda, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 30, 2004
Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptidesAnna Valerio, Daniela Basso, Paola Fogar, et al.
Annals of Surgery|June 21, 2016
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNMGiovanni Marchegiani, Stefano Andrianello, Giuseppe Malleo, et al.
Annals of Surgery|June 10, 2016
Multicenter, Prospective Trial of Selective Drain Management for Pancreatoduodenectomy Using Risk StratificationMatthew T McMillan, Giuseppe Malleo, Claudio Bassi, et al.
Oncoimmunology|September 22, 2017
A circulating T<sub>H</sub>2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinomaGeny Piro, Francesca Simionato, Carmine Carbone, et al.
Neuroendocrinology|January 28, 2021
Dual-Tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT Scan and G1-G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Evaluation of 124 Nonmetastatic Resected CasesSalvatore Paiella, Luca Landoni, Sarah Tebaldi, et al.
Archives of Surgery (Chicago, Ill. : 1960)|January 23, 2008
Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trialsGiovanni Butturini, Deborah D Stocken, Moritz N Wente, et al.
Annals of Surgical Oncology|October 13, 2022
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal AdenocarcinomaLaura Maggino, Giuseppe Malleo, Stefano Crippa, et al.
Pageof 43

Showing results (261-270 of 422) with videos related to

Sort By:
Pageof 43
Journal of Gastrointestinal Oncology|April 2, 2016
Variation of tumoral marker after radiofrequency ablation of pancreatic adenocarcinomaMirko D'Onofrio, Emilio Barbi, Roberto Girelli, et al.
Frontiers in Nutrition|June 29, 2023
Independent effect of fat-to-muscle mass ratio at bioimpedance analysis on long-term survival in patients receiving surgery for pancreatic cancerMarta Sandini, Salvatore Paiella, Marco Cereda, et al.
Annals of Surgery|October 9, 2019
Perioperative Interstitial Fluid Expansion Predicts Major Morbidity Following Pancreatic Surgery: Appraisal by Bioimpedance Vector AnalysisMarta Sandini, Salvatore Paiella, Marco Cereda, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 30, 2004
Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptidesAnna Valerio, Daniela Basso, Paola Fogar, et al.
Annals of Surgery|June 21, 2016
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNMGiovanni Marchegiani, Stefano Andrianello, Giuseppe Malleo, et al.
Annals of Surgery|June 10, 2016
Multicenter, Prospective Trial of Selective Drain Management for Pancreatoduodenectomy Using Risk StratificationMatthew T McMillan, Giuseppe Malleo, Claudio Bassi, et al.
Oncoimmunology|September 22, 2017
A circulating T<sub>H</sub>2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinomaGeny Piro, Francesca Simionato, Carmine Carbone, et al.
Neuroendocrinology|January 28, 2021
Dual-Tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT Scan and G1-G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Evaluation of 124 Nonmetastatic Resected CasesSalvatore Paiella, Luca Landoni, Sarah Tebaldi, et al.
Archives of Surgery (Chicago, Ill. : 1960)|January 23, 2008
Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trialsGiovanni Butturini, Deborah D Stocken, Moritz N Wente, et al.
Annals of Surgical Oncology|October 13, 2022
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal AdenocarcinomaLaura Maggino, Giuseppe Malleo, Stefano Crippa, et al.
Pageof 43